Lyka Labs informs about outcome of board meeting

25 Nov 2017 Evaluate

Lyka Labs has informed about the Board of Directors at their meeting held on 24th November, 2017 has considered un- audited standalone financial results for the second quarter and six months ended 30th September, 2017.

The above information is a part of company’s filings submitted to BSE.

Lyka Labs Share Price

77.80 1.34 (1.75%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×